Self assembling diketopiperazine drug delivery system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5352461
SERIAL NO

07849186

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In the most preferred embodiment the microparticles are formed in the presence of the drug to be delivered, for example, insulin or heparin. The diketopiperazine synthetic intermediates are preferably formed by cyclodimerization to form diketopiperazine derivatives at elevated conditions under dehydrating conditions, then precipitated with drug to be incorporated into microparticles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MANNKIND CORPORATION

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feldstein, Robert Pelham, NY 27 1879
Glass, John Shoreham, NY 11 360
Steiner, Solomon S Mt. Kisco, NY 80 4286

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation